Abstract: This disclosure describes systems, methods, and apparatus for detecting and displaying a number of rounds in a firearm magazine comprising a maximum number of N rounds. The magazine may comprise a follower, magnets on the follower, and <N magnetic switches arranged along a path of the magnets when the follower moves along a length of the magazine, the switches configured to activate based on a magnetic field exceeding a threshold, and a first antenna arranged on an inside of the magazine and parallel to a firing direction of the firearm, and configured to wirelessly transmit a round count indication to a second antenna on the firearm, the round count indication based on the round count data, the second antenna affixed to an inside of a magazine well of the firearm and mostly overlapping with the first antenna.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.

Abstract: According to various embodiments of the invention, systems and methods are provided for manufacturing a tubular container with a seal and release mechanism. Specifically, in accordance with one embodiment, a method for manufacturing a tubular container is provided, comprising: creating a tube having a first end and a second end, wherein the first and second ends are open; sealing the first end of the tube; scoring the tube at a predetermined location such that the tube at the predetermined position is made easier to break relative to other locations along the tube; loading the tube into a collection unit such that the second end is positioned for filling; filling the tube with a predetermined amount of a selected liquid; and filling the tube with a liquid blocker after filling the selected liquid, wherein the liquid blocker inhibits the flow of the selected liquid and seals the selected liquid inside the tube.

Abstract: A spinal plate is provided that has two components of curvature in the lower surface that opposes the spinal vertebrae. This lower surface preferrably has the shape of a toroidal segment. A series of plates may be taken from a principal "s"-shaped template of similar shape on its lower surface. For convenience of manufacture, the shape of the curvature of the "S"-shaped template along the sides of the template is circular. A special hole pattern is also disclosed in respect of a tapered thoracic portion of the template.